Vibrio fluvialis in Patients with Diarrhea, Kolkata, India
Goutam Chowdhury, Gururaja P. Pazhani, Devarati Dutta, Sucharita Guin, Sanjucta Dutta, Santanu Ghosh, Hidemasa Izumiya, Masahiro Asakura, Shinji Yamasaki, Yoshifumi Takeda, Eiji Arakawa, Haruo Watanabe, Asish K. Mukhopadhyay, Mihir K. Bhattacharya, K. Rajendran, Gopinath Balakrish Nair, and Thandavarayan Ramamurthy
Author affiliations: National Institute of Cholera and Enteric Diseases, Kolkata, India (G. Chowdhury, G.P. Pazhani, D. Dutta, S. Guin, S. Dutta, S. Ghosh, A.K. Mukhopadhyay, M.K. Bhattacharya, K. Rajendran, G. Nair, T. Ramamurthy); National Institute of Infectious Diseases, Tokyo, Japan (H. Izumiya, E. Arakawa, H. Watanabe); Osaka Prefecture University Graduate School of Life and Environmental Sciences, Osaka, Japan (M. Asakura, S. Yamasaki); and National Institute of Cholera and Enteric Diseases Collaborative Research Center of Okayama University for Infectious Diseases in India, Kolkata (Y. Takeda).
Main Article
Figure
Figure. . . . Dendrogram of NotI-digested pulsed-field gel electrophoresis (PFGE) profiles with representative Vibrio fluvialis isolates. Clustering identified 4 clades (A–D). AM, ampicillin; S, streptomycin; G, gentamicin; NA, nalidixic acid; CIP, ciprofloxacin; C, chloramphenicol; E, erythromycin; SXT, sulfamethoxazole-trimethoprim; FZ, furazolidone; NOR, norfloxacin. Scale bar indicates degree of similarity.
Main Article
Page created: October 16, 2012
Page updated: October 16, 2012
Page reviewed: October 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.